Page not found

Search results

  1. “Driving Innovation in Breast Cancer”, new startup challenge centers on breast cancer innovation

    ... They are searching for teams interested in starting a new venture based on one of the nation’s most promising breast cancer ...

    cttc_admin - 02/21/2019 - 9:51am

  2. A new target for lung cancer

    ... requirements during lung cancer progression and is a new vulnerability and potential therapeutic target in lung cancer. The study ...

    sommers - 02/21/2019 - 9:51am

  3. Team’s findings could spur new treatments for type 2 diabetes

    ... journal  Nature Medicine , could lead to development of new ways to treat type 2 diabetes. “The most common drug to manage ...

    sommers - 02/21/2019 - 9:51am

  4. New Venture News: NV Director talks supporting startups at national conference

    03/29/2013 Peter Rousos, director of new venture development with Vanderbilt CTTC, recently served on a panel at the ...

    cttc_admin - 01/07/2019 - 8:00am

  5. New study shows Play Nicely™ program is an effective positive parenting strategy

    09/07/2016 A new study shows the Play Nicely™ program, developed by Seth Scholer at ...

    steelmk - 09/07/2016 - 4:22pm

  6. Novel genetic study sheds new light on risk of heart attack

    ... and thus is a potential target in the development of new anti-cancer drugs. But what does it do when it’s not killing cells? ...

    sommers - 02/21/2019 - 9:51am

  7. New lipid shape atlas holds key to early disease detection

    ... scholar, said the work was made possible by a relatively new technology called ion mobility-mass spectrometry, which allows scientists ...

    sommers - 03/11/2019 - 1:07pm

  8. A new regulator of B cell development

    10/11/2019 Interleukin-33 (IL-33) drives inflammatory responses in allergic and nonallergic disease. Epithelial cells in the lungs, gastrointestinal tract and elsewhere release IL-33, which activates the ST2 receptor on immune...

    sommers - 10/11/2019 - 9:41am

  9. New window on fibrosis

    08/14/2019 DDR1 is a receptor tyrosine kinase (RTK) — a cell surface receptor — that regulates multiple functions including the maintenance of the normal structure of tissues, but which also contributes to pathological conditions...

    sommers - 08/14/2019 - 8:16am

  10. Correctly copying DNA - new research from Neil Osheroff

    03/18/2019 The enzyme topoisomerase II resolves topological roadblocks that form during the copying and expression of genetic material by generating double-stranded breaks in one DNA segment, transporting another DNA segment...

    sommers - 03/18/2019 - 2:12pm